Indian Journal of Critical Care Medicine

Register      Login



Volume / Issue

Online First

Related articles

VOLUME 25 , ISSUE 3 ( March, 2021 ) > List of Articles


Melioidosis—Commonly Missed, Yet Not Uncommon and Eminently Treatable

Ram Gopalakrishnan

Citation Information : Gopalakrishnan R. Melioidosis—Commonly Missed, Yet Not Uncommon and Eminently Treatable. Indian J Crit Care Med 2021; 25 (3):258-259.

DOI: 10.5005/jp-journals-10071-23749

License: CC BY-NC 4.0

Published Online: 01-05-2021

Copyright Statement:  Copyright © 2021; The Author(s).


  1. Limmathurotsakul D, Golding N, Dance D, Messina JP, Pigott DM, Moyes CL, et al. Predicted global distribution of Burkholderia pseudomallei and burden of melioidosis. Nat Microbiol 2016;1(1):15008. DOI: 10.1038/nmicrobiol.2015.8.
  2. Arjun R, Ghafur A, Devarajan V, Senthur Nambi P, Ramasubramanian V, Suresh Kumar D, et al. A cluster of cases of melioidosis following floods in Chennai, India. J Contemp Clin Pract 2017;3(2):50–56. DOI: 10.18683/jccp.2017.
  3. Chierakul W, Winothai W, Wattanawaitunechai C, Wuthiekanun V, Rugtaengan T, Rattanalertnavee J. Melioidosis in 6 tsunami survivors in Southern Thailand. Clin Infect Dis 2005;41(7):982–990. DOI: 10.1086/432942.
  4. Solomon CG, LaRocque RC. Climate change—a health emergency. N Engl J Med 2019;380(3):209–211. DOI: 10.1056/NEJMp1817067.
  5. Ganesan V, Murugan M, Sundaramurthy R, Soundaram GVG. Melioidosis in a tertiary care center from South India—a 5-year experience. Indian J Crit Care Med 2021;25(3):327–330.
  6. Gopalakrishnan R, Sureshkumar D, Thirunarayan MA, Ramasubramanian V. Melioidosis: an emerging infection in India. J Assoc Physic India 2013;61(9):24–26.
  8. Russo TA, Marr CM. Hypervirulent Klebsiella pneumonia. Clin Microbiol Rev 2019;32(3):e0000119. DOI: 10.1128/CMR.00001-19.
  9. Anunnatsiri S, Chaowagul W, Teparrukkul P, Chetchotisakd P, Tanwisaid K, Khemla S, et al. A comparison between 12 versus 20 weeks of trimethoprim-sulfamethoxazole as oral eradication treatment for melioidosis: an open-label, pragmatic, multicenter, non-inferiority, randomized controlled trial. Clin Infect Dis 2020;ciaa1084. DOI: 10.1093/cid/ciaa1084.
  10. Chetchotisakd P, Chierakul W, Chaowagul W, Anunnatsiri S, Phimda K, Mootsikapun P, et al. Trimethoprim-sulfamethoxazole versus trimethoprim-sulfamethoxazole plus doxycycline as oral eradicative treatment for melioidosis (MERTH): a multicentre, double-blind, non-inferiority, randomised controlled trial. Lancet 2014;383(9919):807–814. ISSN 0140-6736. DOI: 10.1016/S0140-6736(13)61951-0.
PDF Share
PDF Share

© Jaypee Brothers Medical Publishers (P) LTD.